Home > Income Statement > CORONA REMEDIES

CORONA REMEDIES
Consolidated Net Profit

    Back to Income Statement
CORONA REMEDIES is part of below Screeners ↓
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CORONA REMEDIES
Please provide your vote to see the results

CORONA REMEDIES Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2026Mar2025Mar2024Mar2023
Consolidated Net Profit ₹149 Cr₹905 Cr₹85 Cr₹85 Cr

What is the latest Consolidated Net Profit of CORONA REMEDIES ?

The latest Consolidated Net Profit ratio of CORONA REMEDIES is ₹149 Cr based on Mar2026 Consolidated results.
Year Consolidated Net Profit
Mar2026₹149 Cr
Mar2025₹905 Cr
Mar2024₹85 Cr
Mar2023₹85 Cr

How is Consolidated Net Profit of CORONA REMEDIES Trending?

Years Consolidated Net Profit % Change
Mar2026 ₹149 Cr
-83.49
Mar2025 ₹905 Cr
965.63
Mar2024 ₹85 Cr
0.00
Mar2023 ₹85 Cr -

Compare Consolidated Net Profit of peers of CORONA REMEDIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CORONA REMEDIES ₹13,551.5 Cr -1.7% 3.5% NA Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹448,196.0 Cr -0.4% -3.3% 15.5% Stock Analytics
DIVIS LABORATORIES ₹250,390.0 Cr 0.4% 9.9% 55.1% Stock Analytics
TORRENT PHARMACEUTICALS ₹188,967.0 Cr -3.4% -4.2% 37.1% Stock Analytics
CIPLA ₹111,888.0 Cr 0.5% -3.2% -12.8% Stock Analytics
DR REDDYS LABORATORIES ₹100,329.0 Cr 0.9% 0% -11% Stock Analytics


CORONA REMEDIES Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CORONA REMEDIES

-1.7%

3.5%

NA
SENSEX

0.1%

-2.7%

-8.6%


You may also like the below Video Courses